Table 4.
Hydrodynamic radius (RH) and zeta potential (ζ) of LVF–CH/TPP3 NPs and LVF–CH/SBE-β-CD3 NPs in the presence of lysozyme (1 mg/mL).
| NPs Sample | t (h) | RH ± S.D. (nm) | PDI % | ζ ± S.D. (mV) |
|---|---|---|---|---|
| LVF–CH/TPP3 + lysozyme | 0 | 86 ±38 | 21 | +26.1 ± 5.0 |
| 0.5 | 86 ± 38 | 21 | +25.8 ± 5.2 | |
| 1 | 81 ± 34 | 20 | +26.3 ± 5.3 | |
| 3 | 77 ± 30 | 21 | +26.9 ± 4.5 | |
| 5 | 76 ± 32 | 20 | +26.3 ± 4.4 | |
| 7 | 75 ± 33 | 20 | +25.6 ± 4.5 | |
| 24 | 65 ± 25 | 20 | +25.3 ± 5.0 | |
| 48 | 63 ± 27 | 21 | +24.8 ± 4.1 | |
| 72 | 62 ± 26 | 19 | +23.3 ± 4.8 | |
| 96 | 58 ± 23 | 20 | +24.3 ± 4.6 | |
| LVF–CH/SBE-β-CD3 + lysozyme | 0 | 159 ± 52 | 16 | +23.8 ± 5.3 |
| 0.5 | 157 ± 64 | 16 | +24.6 ± 5.4 | |
| 1 | 157 ± 70 | 17 | +23.3 ± 4.5 | |
| 3 | 146 ± 58 | 15 | +23.0 ± 5.8 | |
| 5 | 143 ± 57 | 17 | +24.1 ± 5.0 | |
| 7 | 134 ± 56 | 21 | +23.9 ± 4.4 | |
| 24 | 116 ± 48 | 20 | +23.7 ± 4.0 | |
| 48 | 104 ± 43 | 18 | +23.9 ± 4.1 | |
| 72 | 98 ± 43 | 21 | +24.2 ± 3.4 | |
| 96 | 82 ± 29 | 24 | +24.2 ± 4.0 |